Company News

The first cohort of the Graduate Research Training Initiative for Student Enhancement (G-RISE) will arrive at Old Dominion University this summer on their path to make a lasting impact in the field of biomedical research. G-RISE is designed increase the diversity of biomedical researchers by attracting underrepresented students from minority, military, socioeconomically disadvantaged and disability …

The Dominion Energy Innovation Center (“DEIC”) announced the eight startups that will make up the 2021 DEIC Accelerate cohort running from late May into September. “Clean energy products and technologies will benefit our communities and fast-track our endeavors to produce sustainable, green solutions,” said Senior Vice President and Chief Innovation Officer Mark Webb. “DEIC’s Accelerate …

Office Space Available: Do you need a small office for your life science or advanced tech startup? The VA Bio+Tech Park in downtown Richmond has two offices available to fit 1-2 people. Find out more here or contact Heather.Allen@vabiotech.com. Shared Lab Space Available: Do you need to run a test but don’t have a dedicated lab? The VA …

Ceres Nanosciences announced it has been awarded an $8.2 million contract from the National Institutes of Health’s Rapid Acceleration of Diagnostics Initiative. The funding will support the development and implementation of wastewater-based surveillance systems for COVID-19. Manassas, Virginia-based Ceres plans to develop surveillance systems using its Nanotrap particle technology at a network of sites, with …

The Greater Richmond Partnership (“GRP”), the lead regional economic development organization serving the City of Richmond and counties of Chesterfield, Hanover and Henrico in Virginia, announces that Mitchel Allen-Rivera is the new Executive Vice President of Business Development. “I am thrilled to welcome Mitchel to Greater Richmond to lead business development,” said Jennifer Wakefield, President …

Case Western Reserve University and Atelerix Life Sciences Inc., a Charlottesville, Virginia-based biotechnology company, have signed a two-year option to license a novel family of small molecules called Active Thiol-Based Compounds (ATBC’s) to prevent or reverse life-threatening opioid-related side effects. The lead compound, ATLX–0199 (also called sudaxine), will be first targeted at opioid-induced respiratory depression …